MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKKGY) Sees Large Decrease in Short Interest

MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKKGYGet Rating) was the target of a large decrease in short interest in April. As of April 30th, there was short interest totalling 1,700 shares, a decrease of 61.4% from the April 15th total of 4,400 shares. Based on an average daily trading volume, of 122,400 shares, the days-to-cover ratio is presently 0.0 days.

Separately, Morgan Stanley increased their price objective on MERCK Kommanditgesellschaft auf Aktien from €220.00 ($231.58) to €225.00 ($236.84) and gave the company an “equal weight” rating in a research report on Friday, April 29th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, MERCK Kommanditgesellschaft auf Aktien currently has a consensus rating of “Hold” and a consensus target price of $247.50.

MKKGY opened at $35.08 on Thursday. The business has a 50 day moving average price of $39.09 and a 200 day moving average price of $43.91. MERCK Kommanditgesellschaft auf Aktien has a twelve month low of $32.71 and a twelve month high of $52.29.

About MERCK Kommanditgesellschaft auf Aktien (Get Rating)

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology.

See Also

Receive News & Ratings for MERCK Kommanditgesellschaft auf Aktien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MERCK Kommanditgesellschaft auf Aktien and related companies with MarketBeat.com's FREE daily email newsletter.